Inhaled Nitric Oxide for Patients With MABSC

PHASE2CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

July 24, 2017

Primary Completion Date

May 1, 2018

Study Completion Date

April 11, 2019

Conditions
Mycobacterium Abscessus Infection
Interventions
DRUG

Nitric Oxide

Subjects will be treated with 91 thirty minute sessions of 160 ppm Nitric Oxide with at least 3 hours between each session.

Trial Locations (1)

Unknown

Rambam Medical Center, Haifa

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Beyond Air Inc.

INDUSTRY